Michael R. Loken

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Cytokine-mediated CAR T therapy resistance in AML”.

Cytokine-mediated CAR T therapy resistance in AML

Nature Medicine(2024)10.1038/s41591-024-03271-5

N/A

2.2DataRank · unranked

90 citations

Leonel Torres, Olga Shestova, Maksim Shestov, Patrick Mellors, Han R Fisher +24 more

Molecular risk markers define risk of relapse in myeloid leukemia of Down syndrome beyond measurable residual disease

Blood Advances(2025)10.1182/bloodadvances.2025017837

N/A

0.104DataRank · unranked

1 citations

Anupam Verma, Shelton A. Viola, Todd A. Alonzo, Yicheng Wang, Lisa Eidenschink Brodersen +15 more

Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia

Blood Advances(2021)10.1182/bloodadvances.2021004424

N/A

0DataRank · unranked

41 citations

Sonali P. Barwe, Anilkumar Gopalakrishnapillai, Rhonda E. Ries, Todd A. Alonzo, Robert B. Gerbing +16 more

A B-cell developmental gene regulatory network is activated in infant AML

PLoS ONE(2021)10.1371/journal.pone.0259197

N/A

0DataRank · unranked

13 citations

Rhonda E. Ries, Laura Pardo, Tiffany Hylkema, Wanding Zhou, Jenny L. Smith +6 more

Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia

Haematologica(2023)10.3324/haematol.2022.281653

N/A

0DataRank · unranked

76 citations

Jenny L. Smith, Lauren Harmon, Rhonda E. Ries, Yi-Cheng J. Wang, Todd A. Alonzo +32 more

CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children’s Oncology Group

Blood(2021)10.1182/blood.2020009652

N/A

0DataRank · unranked

122 citations

Adam J. Lamble, Yi‐Cheng Wang, Robert B. Gerbing, Rhonda E. Ries, Michael R. Loken +13 more

CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children’s Oncology Group

Haematologica(2024)10.3324/haematol.2023.283757

N/A

0DataRank · unranked

10 citations

Chad A. Hudson, Todd A. Alonzo, Robert B. Gerbing, Laura Pardo, Amanda R. Leonti +18 more

Addressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children’s Hospital at Baylor College of Medicine

Biomedicines(2024)10.3390/biomedicines12020394

N/A

0DataRank · unranked

8 citations

Maci Terrell, Raushan Rashid, Kevin E. Fisher, Andrea N. Marcogliese, Amos Gaikwad +15 more

Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response

Leukemia(2024)10.1038/s41375-024-02426-0

N/A

0DataRank · unranked

0 citations

Eric D Duncavage, Ajay Khanna, Gue Su Chang, Sridhar Nonavinkere Srivatsan, Christopher A. Miller +22 more

Novel CD33 Antibodies Unravel Localization, Biology and Therapeutic Implications of CD33 Isoforms

Future Oncology(2020)10.2217/fon-2020-0746

N/A

0DataRank · unranked

7 citations

Vivek M. Shastri, Tiffany Hylkema, Ioannis Papageorgiou, Laura Pardo, Christopher R. Cogle +5 more